Skip to main content

Volume 1 - Issue 3 - September 2021

03/07/2022
Table of Contents and Whole Issue PDF
Table of Contents and Whole Issue PDF
Table of Contents and Whole...
03/07/2022
Journal of Critical Limb Ischemia
Original Contribution
09/28/2021
M. Imran Ghare, MD; Cody Pietras, BA; Daniela Tirziu, PhD; Helen Parise, ScD; Roseann White, PhD; S. Elissa Altin, MD; Sameer Nagpal, MD; Alexandra J. Lansky, MD
The authors selected studies reporting amputation-free survival (AFS) in patients with non-revascularizable Rutherford category 5/6 CLI at a minimum follow-up of 6 months.
The authors selected studies reporting amputation-free survival (AFS) in patients with non-revascularizable Rutherford category 5/6 CLI at a minimum follow-up of 6 months.
The authors selected studies...
09/28/2021
Journal of Critical Limb Ischemia
Editorial/Commentary
09/28/2021
Nicholas J. Reid, BSc; Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI
An editorial commentary on Ghare et al's "Outcomes among patients with chronic critical limb ischemia with no revascularization option: systematic review and meta-analysis."
An editorial commentary on Ghare et al's "Outcomes among patients with chronic critical limb ischemia with no revascularization option: systematic review and meta-analysis."
An editorial commentary on Ghare...
09/28/2021
Journal of Critical Limb Ischemia
Original Contribution
09/28/2021
Jihad A. Mustapha, MD, FACC, FSCAI; Fadi Saab, MD, FACC, FSCAI; Theresa McGoff, BSN; Sara Finton, BSN; George L. Adams, MD, MHS, MBA, FACC, FSCAI; J. Randall Mullins, MD; Michael R. Jaff, MD, DO; Farhan Khawaja, MD; Philip P. Goodney, MD; Gabor Matos, MD; M. Laiq Raja, MD; Michael Sumners, DO
The objective of this study was to determine the relationship between patients diagnosed with PAD/CLI, with CTOs, and subsequent long-term outcomes.
The objective of this study was to determine the relationship between patients diagnosed with PAD/CLI, with CTOs, and subsequent long-term outcomes.
The objective of this study was...
09/28/2021
Journal of Critical Limb Ischemia
Editorial/Commentary
09/28/2021
Terrence Chi Hong Hui, MBBS, MRCSI, FRCR, MMed; Uei Pua, MD
Editorial commentary on Mustapha et al's "Chronic total occlusions: association between characteristics and long-term outcomes in critical limb ischemia."
Editorial commentary on Mustapha et al's "Chronic total occlusions: association between characteristics and long-term outcomes in critical limb ischemia."
Editorial commentary on Mustapha...
09/28/2021
Journal of Critical Limb Ischemia
Original Contribution
09/28/2021
Omid Shafe, MD; Ehsan Samiee, MD; Jamal Moosavi, MD; Bahram Mohebbi, MD; Amir A. Fakhrabadi, MD; Hooman Bakhshandeh, MD, PhD; Batoul Naghavi, MD, MPH; Reza Tahivili; Saeed Cheraghi; Parham Sadeghipour, MD
This randomized, controlled trial was designed to compare the rate of postangiographic contrast-induced nephropathy between the intra-arterial injections of carbon dioxide and the iodinated contrast agent.
This randomized, controlled trial was designed to compare the rate of postangiographic contrast-induced nephropathy between the intra-arterial injections of carbon dioxide and the iodinated contrast agent.
This randomized, controlled...
09/28/2021
Journal of Critical Limb Ischemia
Original Contribution
09/28/2021
Joji J. Varghese, MD, FACC, FSCAI; Bailey Ann Estes MSN, AGNP-C, RN-BC, RNFA, CNOR, RCIS; Brad J. Martinsen, PhD; Zsuzsanna Igyarto, PhD; Srihari S. Naidu MD, MSCAI; Fadi Saab, MD, FACC, FSCAI; Jihad A. Mustapha, MD, FACC, FSCAI
The authors evaluated the 7-year mortality of patients undergoing major and minor lower-extremity amputations and determined the impact of risk factors on long-term mortality.
The authors evaluated the 7-year mortality of patients undergoing major and minor lower-extremity amputations and determined the impact of risk factors on long-term mortality.
The authors evaluated the 7-year...
09/28/2021
Journal of Critical Limb Ischemia
Original Contribution, Review
09/28/2021
Jihad A. Mustapha, MD, FACC, FSCAI; Fadi Saab, MD, FACC, FSCAI; Brad J. Martinsen, PhD; Ann N. Behrens, BS; Miguel Montero-Baker, MD; Bret N. Wiechmann, MD, FSIR, FAHA; Eric C. Scott, MD; David G. Armstrong, DPM, MD, PhD; Nicolas W. Shammas, MD, MS, FACC, FSCAI, FACP, FSVM; George L. Adams, MD, MHS, MBA, FACC, FSCAI
The authors review the mechanism of action of OA, supporting clinical study evidence, and corresponding economic analyses.
The authors review the mechanism of action of OA, supporting clinical study evidence, and corresponding economic analyses.
The authors review the mechanism...
09/28/2021
Journal of Critical Limb Ischemia